{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:03:35Z","timestamp":1746763415987,"version":"3.40.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,8]]},"DOI":"10.7759\/cureus.83720","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:05:07Z","timestamp":1746705907000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Fatal Case of Hemophagocytic Lymphohistiocytosis With Central Pontine Myelinolysis in the Setting of Epstein-Barr Virus Reactivation"],"prefix":"10.7759","author":[{"given":"Alexander C","family":"Goodman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin J","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Tullberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin G","year":"2020","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020, 34:101515. 10.1016\/j.berh.2020.101515","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102143","article-title":"Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006-19: a national, retrospective cohort study","volume":"62","author":"Abdelhay A","year":"2023","unstructured":"Abdelhay A, Mahmoud AA, Al Ali O, Hashem A, Orakzai A, Jamshed S. Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006-19: a national, retrospective cohort study. EClinicalMedicine. 2023, 62:102143. 10.1016\/j.eclinm.2023.102143","journal-title":"EClinicalMedicine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2012.744122","article-title":"Fulminant hemophagocytic lymphohistiocytosis secondary to a reactivated EBV infection: a case report","volume":"118","author":"Antonodimitrakis P","year":"2013","unstructured":"Antonodimitrakis P, Wassberg C, Gerovasileiou S, Back J, H\u00e4llgren R, Olsen B. Fulminant hemophagocytic lymphohistiocytosis secondary to a reactivated EBV infection: a case report. Ups J Med Sci. 2013, 118:42-5. 10.3109\/03009734.2012.744122","journal-title":"Ups J Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/frhem.2022.983424","article-title":"Case report: Reactive Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and thrombosis with thrombocytopenia syndrome following SARS-CoV-2 vaccination and treated with intravenous immunoglobulin","volume":"1","author":"Chang Y-S","year":"2022","unstructured":"Chang Y-S, Ye J-J, Cheng T-C, et al.. Case report: Reactive Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and thrombosis with thrombocytopenia syndrome following SARS-CoV-2 vaccination and treated with intravenous immunoglobulin. Front Hematol. 2022, 1:10.3389\/frhem.2022.983424","journal-title":"Front Hematol"},{"key":"ref5","article-title":"A case report of hemophagocytic lymphohistiocytosis (HLH) brought on by EBV reactivation on durvalumab","volume":"13","author":"Maury A","year":"2023","unstructured":"Maury A. A case report of hemophagocytic lymphohistiocytosis (HLH) brought on by EBV reactivation on durvalumab. Clin Investig. 2023, 13:365-8.","journal-title":"Clin Investig"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.25259\/IJMS_194_2020","article-title":"Hemophagocytic lymphohistiocytosis following reactivation of Epstein-Barr virus infection - a rare case report","volume":"73","author":"Sundaram C","year":"2021","unstructured":"Sundaram C, Shriramganesh RT, Sangeetha G. Hemophagocytic lymphohistiocytosis following reactivation of Epstein-Barr virus infection - a rare case report. Indian J Med Sci. 2021, 73:264-5. 10.25259\/IJMS_194_2020","journal-title":"Indian J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/652752","article-title":"Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis","volume":"201","author":"Toga A","year":"2010","unstructured":"Toga A, Wada T, Sakakibara Y, et al.. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. J Infect Dis. 2010, 201:1923-32. 10.1086\/652752","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1086\/653424","article-title":"Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells","volume":"51","author":"Fox CP","year":"2010","unstructured":"Fox CP, Shannon-Lowe C, Gothard P, Kishore B, Neilson J, O'Connor N, Rowe M. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells. Clin Infect Dis. 2010, 51:66-9. 10.1086\/653424","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13736","article-title":"Serious consequences of Epstein-Barr virus infection: hemophagocytic lymphohistocytosis","volume":"44","author":"Xu L","year":"2022","unstructured":"Xu L, Guo X, Guan H. Serious consequences of Epstein-Barr virus infection: hemophagocytic lymphohistocytosis. Int J Lab Hematol. 2022, 44:74-81. 10.1111\/ijlh.13736","journal-title":"Int J Lab Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01902","article-title":"Epstein-Barr virus and hemophagocytic lymphohistiocytosis","volume":"8","author":"Marsh RA","year":"2017","unstructured":"Marsh RA. Epstein-Barr virus and hemophagocytic lymphohistiocytosis. Front Immunol. 2017, 8:1902. 10.3389\/fimmu.2017.01902","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000202712","article-title":"Central pontine myelinolysis in a patient with hepatosplenic T cell lymphoma and hemophagocytic lymphohistiocytosis","volume":"100","author":"Avila S","year":"2023","unstructured":"Avila S, Aw A, Danziger R, Kim C, Tan C, Schlick K. Central pontine myelinolysis in a patient with hepatosplenic T cell lymphoma and hemophagocytic lymphohistiocytosis. Neurology. 2023, 100:2670-10. 10.1212\/WNL.0000000000202712","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000016032","article-title":"EBV associated hemophagocytic syndrome accompanied by central pontine myelinolysis","volume":"43","author":"Uehara E","year":"2002","unstructured":"Uehara E, Tasaka T, Matsuhashi Y, et al.. EBV associated hemophagocytic syndrome accompanied by central pontine myelinolysis. Leuk Lymphoma. 2002, 43:2047-50. 10.1080\/1042819021000016032","journal-title":"Leuk Lymphoma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0802-RA","article-title":"Hemophagocytic lymphohistiocytosis","volume":"146","author":"Ponnatt TS","year":"2022","unstructured":"Ponnatt TS, Lilley CM, Mirza KM. Hemophagocytic lymphohistiocytosis. Arch Pathol Lab Med. 2022, 146:507-19. 10.5858\/arpa.2020-0802-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter JI","year":"2025","unstructured":"Henter JI. Hemophagocytic lymphohistiocytosis. N Engl J Med. 2025, 392:584-98. 10.1056\/NEJMra2314005","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter JI","year":"2002","unstructured":"Henter JI, Samuelsson-Horne A, Aric\u00f2 M, et al.. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002, 100:2367-73. 10.1182\/blood-2002-01-0172","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e P","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, et al.. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019, 133:2465-77. 10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195799","article-title":"Anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases","volume":"11","author":"Baverez C","year":"2022","unstructured":"Baverez C, Grall M, Gerfaud-Valentin M, et al.. Anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases. J Clin Med. 2022, 11:5799. 10.3390\/jcm11195799","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000847836.30971.66","article-title":"P1243: ruxolitinib combined with dexamethasone in adult patients with newly diagnosed hemophagocytic lymphohistiocytosis: interim analysis of a prospective, single-center, single-arm, phase 2 clinical trial","volume":"6","author":"Zhou D","year":"2022","unstructured":"Zhou D, Huang X, Li X, et al.. P1243: ruxolitinib combined with dexamethasone in adult patients with newly diagnosed hemophagocytic lymphohistiocytosis: interim analysis of a prospective, single-center, single-arm, phase 2 clinical trial. Hemasphere. 2022, 6:1128-9. 10.1097\/01.HS9.0000847836.30971.66","journal-title":"Hemasphere"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli M","year":"2019","unstructured":"Vallurupalli M, Berliner N. Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis. Blood. 2019, 134:1783-6. 10.1182\/blood.2019002289","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000797","article-title":"Temporal trends in the incidence of hemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003-2018","volume":"6","author":"West J","year":"2022","unstructured":"West J, Stilwell P, Liu H, et al.. Temporal trends in the incidence of hemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003-2018. Hemasphere. 2022, 6:e797. 10.1097\/HS9.0000000000000797","journal-title":"Hemasphere"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1503118","article-title":"A predictive model for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"15","author":"Huang R","year":"2024","unstructured":"Huang R, Wu D, Wang L, et al.. A predictive model for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Front Immunol. 2024, 15:1503118. 10.3389\/fimmu.2024.1503118","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24319","article-title":"Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis","volume":"60","author":"Ito Y","year":"2013","unstructured":"Ito Y, Kawamura Y, Iwata S, Kawada J, Yoshikawa T, Kimura H. Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2013, 60:326-8. 10.1002\/pbc.24319","journal-title":"Pediatr Blood Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.212.supp.0799.6149","article-title":"Secondary hemophagocytic lymphohistiocytosis with associated central pontine myelinolysis","volume":"212","author":"Philip R","year":"2024","unstructured":"Philip R, Alam M. Secondary hemophagocytic lymphohistiocytosis with associated central pontine myelinolysis. J Immunol. 2024, 212:0799_6149. 10.4049\/jimmunol.212.supp.0799.6149","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-015-2431-7","article-title":"Epstein-Barr virus infection involving bilateral middle cerebellar peduncles in an old woman: a case report","volume":"37","author":"Shen Y","year":"2016","unstructured":"Shen Y, Tu J, Liu H, Dai T, Wu W. Epstein-Barr virus infection involving bilateral middle cerebellar peduncles in an old woman: a case report. Neurol Sci. 2016, 37:479-81. 10.1007\/s10072-015-2431-7","journal-title":"Neurol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23268","article-title":"Regional oligodendrocytopathy and astrocytopathy precede myelin loss and blood-brain barrier disruption in a murine model of osmotic demyelination syndrome","volume":"66","author":"Bouchat J","year":"2018","unstructured":"Bouchat J, Couturier B, Marneffe C, et al.. Regional oligodendrocytopathy and astrocytopathy precede myelin loss and blood-brain barrier disruption in a murine model of osmotic demyelination syndrome. Glia. 2018, 66:606-22. 10.1002\/glia.23268","journal-title":"Glia"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.05.031","article-title":"Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH steering committee of the Histiocyte Society","volume":"6","author":"Ehl S","year":"2018","unstructured":"Ehl S, Astigarraga I, von Bahr Greenwood T, et al.. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH steering committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018, 6:1508-17. 10.1016\/j.jaip.2018.05.031","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.198655","article-title":"Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy","volume":"104","author":"Yoon JH","year":"2019","unstructured":"Yoon JH, Park SS, Jeon YW, et al.. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019, 104:269-76. 10.3324\/haematol.2018.198655","journal-title":"Haematologica"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107606","article-title":"Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection","volume":"96","author":"Meng GQ","year":"2021","unstructured":"Meng GQ, Wang JS, Wang YN, Wei N, Wang Z. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection. Int Immunopharmacol. 2021, 96:107606. 10.1016\/j.intimp.2021.107606","journal-title":"Int Immunopharmacol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12386","article-title":"Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens","volume":"162","author":"Chellapandian D","year":"2013","unstructured":"Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. 2013, 162:376-82. 10.1111\/bjh.12386","journal-title":"Br J Haematol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00435","article-title":"Haematopoietic stem cell transplantation for primary haemophagocytic lymphohistiocytosis","volume":"7","author":"Lehmberg K","year":"2019","unstructured":"Lehmberg K, Moshous D, Booth C. Haematopoietic stem cell transplantation for primary haemophagocytic lymphohistiocytosis. Front Pediatr. 2019, 7:435. 10.3389\/fped.2019.00435","journal-title":"Front Pediatr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-827485","article-title":"Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis","volume":"132","author":"Lucchini G","year":"2018","unstructured":"Lucchini G, Marsh R, Gilmour K, et al.. Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis. Blood. 2018, 132:2088-96. 10.1182\/blood-2018-01-827485","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2192-6","article-title":"How we treat chronic active Epstein-Barr virus infection","volume":"105","author":"Sawada A","year":"2017","unstructured":"Sawada A, Inoue M, Kawa K. How we treat chronic active Epstein-Barr virus infection. Int J Hematol. 2017, 105:406-18. 10.1007\/s12185-017-2192-6","journal-title":"Int J Hematol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12314","article-title":"Current research on chronic active Epstein-Barr virus infection in Japan","volume":"56","author":"Fujiwara S","year":"2014","unstructured":"Fujiwara S, Kimura H, Imadome K, et al.. Current research on chronic active Epstein-Barr virus infection in Japan. Pediatr Int. 2014, 56:159-66. 10.1111\/ped.12314","journal-title":"Pediatr Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363623-a-rare-fatal-case-of-hemophagocytic-lymphohistiocytosis-with-central-pontine-myelinolysis-in-the-setting-of-epstein-barr-virus-reactivation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:05:08Z","timestamp":1746705908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363623-a-rare-fatal-case-of-hemophagocytic-lymphohistiocytosis-with-central-pontine-myelinolysis-in-the-setting-of-epstein-barr-virus-reactivation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.83720","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,8]]}}}